Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding

@article{Varani1996PharmacologicalAB,
  title={Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding},
  author={K. Varani and S. Gessi and A. Dalpiaz and P. Borea},
  journal={British Journal of Pharmacology},
  year={1996},
  volume={117}
}
1 The binding properties of human platelet A2a adenosine receptors, assayed with the A2a‐selective agonist, [3H]‐2‐[p‐(2‐carboxyethyl)‐phenethylamino]‐5′‐N‐ethylcarboxamidoadenosine ([3H]‐CGS 21680), are masked by a non‐receptorial component, the adenotin site. In order to separate A2a receptors from adenotin sites, human platelet membranes were solubilized with 1% 3‐[(3‐cholamidopropyl)dimethylammonio]‐1‐propanesulphonate (CHAPS). The soluble platelet extract was precipitated with polyethylene… Expand
View on Wiley
europepmc.org
77 Citations
Highly Influential Citations
2
Background Citations
16
Methods Citations
9
Results Citations
2

77 Citations

Citation Type

Citation Type

Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding
[3H]‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes
Adenosine A2A receptors of human circulating blood elements
Caffeine alters A2A adenosine receptors and their function in human platelets.
SCH 58261: A selective A2A adenosine receptor antagonists
Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivo.
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
Guanosine exerts antiplatelet and antithrombotic properties through an adenosine-related cAMP-PKA signaling.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
Pharmacological properties of adenosine receptors and adenosine binding proteins
Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein.
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes
Thermodynamic analysis of agonist and antagonist binding to membrane-bound and solubilized A1 adenosine receptors.
Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
A selective binding site for 3H-NECA that is not an adenosine A2 receptor.
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.
...
1
2
3
4
5
...